Chanelle Pharma, Ireland's largest pharmaceutical manufacturer, has been acquired by Exponent, a UK private equity firm for a significant sum. Learn more about this major deal in the pharmaceutical industry!
Chanelle Pharma, the leading generic pharmaceutical manufacturer in Ireland, has been sold to Exponent, a European private equity firm for a remarkable sum of up to €300 million. Michael H Burke, the founder, finalized the deal with Exponent, marking a significant milestone for the company.
The acquisition of Chanelle Pharma by Exponent signifies a strategic move in the pharmaceutical sector. The sale to the UK private equity company highlights the growth potential and market value of Chanelle Pharma within the industry.
This acquisition represents a shift in ownership for Chanelle Pharma, which has been a key player in the generic pharmaceutical market. The deal solidifies Chanelle Pharma's position as a prominent player in the pharmaceutical manufacturing landscape.
The sale of Chanelle Pharma to Exponent reflects a successful chapter in the company's history and sets the stage for further expansion and development under new ownership.
Michael Burke's decision to sell Chanelle Pharma to Exponent reflects his strategic vision for the company's future and aligns with the evolving landscape of the pharmaceutical industry.
Interesting Facts: - Chanelle Pharma is Ireland's largest indigenous manufacturer of generic pharmaceuticals. - Michael H Burke's entrepreneurial journey and decision-making process have led to the company's significant sale to Exponent, a UK private equity firm.
Chanelle Pharma has been sold by its founder Michael H Burke to Exponent, a European private equity firm, for an undisclosed sum.
Staff briefed that Exponent has acquired largest generic drug manufacturer in State in deal worth about €300m.
Chanelle Pharma, has been sold by its founder Michael H Burke to Exponent, a European private equity firm, it has been confirmed.
Ireland's largest indigenous manufacturer of generic pharmaceuticals, Chanelle Pharma, has been acquired by UK private equity company Exponent.
Chanelle Pharma has been sold by its founder Michael H Burke to Exponent, a UK- and Dublin-based private equity firm. Chanelle, founded in Galway by Burke ...
It's been announced this morning that Ireland's largest indigenous manufacturer of generic pharmaceuticals has been acquired by Exponent.
Galway's Chanelle Pharma has been sold to private equity firm Exponent, in a deal that is reported to be valued at up to €300 million.
Chanelle Pharma – one of the great success stories in Galway's pharmaceutical history – has been sold by its founder Michael H Burke to Exponent, ...
Michael Burke was once in the unusual position of being asked whether his daughter should continue her relationship with Tony McCoy.
Human and animal generics manufacturer Chanelle Pharma, the largest domestic drugmaker in Ireland, was acquired by U.K. private equity firm Exponent.